Tilia Fiduciary Partners, Inc. Bristol Myers Squibb CO Transaction History

Tilia Fiduciary Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $1,210 - $1,344	-19 Reduced 2.01%	927 $59,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $328 - $372	5 Added 0.53%	946 $65,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $273 - $324	4 Added 0.43%	941 $67,000
Q3 2022 Oct 26, 2022	BUY	$0.13 - $76.84 $0 - $384	5 Added 0.54%	937 $65,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $145 - $159	2 Added 0.22%	932 $70,000
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $61 - $73	1 Added 0.11%	930 $68,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $49,822 - $58,081	929 New	929 $58,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tilia Fiduciary Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Tilia Fiduciary Partners, Inc. with notifications on news.